HomeTagsCohort

Cohort

Biotechnology

Moleculin Announces Completion of Third SAD Cohort in Phase 1a Clinical Trial of WP1122

PR Newswire - August 22, 2022

Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, reported preliminary results...

Biotechnology

Moleculin Announces Preliminary Third Cohort Interim Data in Phase 1b/2 Clinical Trial of Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases

PR Newswire - December 28, 2021

Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, reported preliminary interim...